Details of the Drug

General Information of Drug (ID: DM5K66F)

• Drug Name: NNZ-2256

Indication

Disease Entry	ICD 11	Status	REF
Fragile X syndrome	LD55	Phase 2	[1]

• Cross-matching ID: TTD ID: D98UXE

References

• [1] ClinicalTrials.gov (NCT01894958 ) A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome. U.S. National Institutes of Health.